文献速递创伤与烧伤复苏、休克与脓毒症

预测复苏性主动脉内球囊阻断成功:时机在预测患者生存方面超越技术变量

Predicting success of resuscitative endovascular occlusion of the aorta: Timing supersedes variable techniques in predicting patient survival.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论在创伤性不可压迫性出血患者中,年龄、格拉斯哥昏迷评分和球囊充盈前收缩压预测REBOA后生存,REBOA操作技术变量均无预测价值,提示更早准备REBOA可能是改善生存的关键。

本文为Emergent Truncal Hemorrhage Control研究的事后分析,纳入2017至2018年六家一级创伤中心共88例接受REBOA的创伤患者,由现场数据采集员记录自入院起所有时间点,采用逻辑回归构建入院时、REBOA启动时和主动脉阻断后三个时间点的生存预测模型。入院模型选择年龄、格拉斯哥昏迷评分和入院收缩压为显著预测因子(AUROC 0.86,95%CI 0.77-0.94);REBOA启动模型和主动脉阻断后模型选择年龄、格拉斯哥昏迷评分和球囊充盈前即刻收缩压为预测因子(AUROC分别为0.87,95%CI 0.78-0.97和0.90,95%CI 0.81-0.99)。没有任何REBOA操作变量被识别为患者生存的预测因子。作者认为,REBOA启动时患者的血流动力学稳定性比如何启动REBOA更重要,更早准备REBOA置入可能是改善生存的关键。

要点

  • 在88例接受REBOA的创伤患者中,入院模型以年龄、格拉斯哥昏迷评分和入院收缩压预测生存,AUROC 0.86(95%CI 0.77-0.94)。
  • REBOA启动模型和主动脉阻断后模型均以年龄、格拉斯哥昏迷评分和球囊充盈前收缩压预测生存,AUROC分别为0.87(95%CI 0.78-0.97)和0.90(95%CI 0.81-0.99)。
  • 没有任何REBOA操作变量(包括操作时间、入路部位、技术、鞘管尺寸、导管长度、球囊容积、置入区域)被识别为患者生存的预测因子。
  • 作者认为,REBOA启动时患者的血流动力学稳定性比如何启动REBOA更重要,更早准备REBOA置入可能是改善生存的关键。

适用人群与场景

  • 创伤性不可压迫性出血、接受REBOA进行临时主动脉阻断的患者;数据来自2017至2018年六家一级创伤中心的前瞻性观察性研究。

研究设计与关键结果

  • 研究类型:大型多中心前瞻性观察性研究(Emergent Truncal Hemorrhage Control Study)的事后分析,六家一级创伤中心,2017至2018年,共88例患者置入REBOA,现场数据采集员记录自入院起所有时间点。
  • 入院模型:年龄、格拉斯哥昏迷评分、入院收缩压为生存的显著预测因子,AUROC 0.86(95%CI 0.77-0.94)。
  • REBOA启动模型:年龄、格拉斯哥昏迷评分、球囊充盈前即刻收缩压为生存预测因子,AUROC 0.87(95%CI 0.78-0.97)。
  • 主动脉阻断后模型:年龄、格拉斯哥昏迷评分、球囊充盈前即刻收缩压为生存预测因子,AUROC 0.90(95%CI 0.81-0.99)。
  • 没有任何REBOA操作变量被识别为患者生存的预测因子。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究的事后分析;证据等级:治疗性,level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,REBOA启动时患者的血流动力学稳定性比如何启动REBOA更重要;这些发现提示更早准备REBOA置入可能是改善生存的关键。
  • 选择REBOA候选者时,年龄、神经状态(格拉斯哥昏迷评分)和休克严重程度(收缩压)是应重点考虑的临床因素;REBOA操作技术变量未显示与生存相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Resuscitative endovascular occlusion of the aorta (REBOA) is used for temporary aortic occlusion of trauma patients in the management of noncompressible hemorrhage. Previous studies have focused on how to properly perform REBOA in the trauma environment to improve survival rates, but high-grade evidence defining the ideal patient population does not yet exist. This post hoc analysis of the Emergent Truncal Hemorrhage Control Study seeks to identify the most important clinical factors for physicians to consider when selecting for REBOA candidates and their potential survival following REBOA.

METHODS: Post hoc analysis of a large, multicenter, prospective observational study conducted at six level 1 trauma centers, 2017 to 2018, was performed. An onsite data collector documented all time points for REBOA patients since admission. Candidate predictors were demographics; injury severity; physiology preprocedure, during procedure, and postprocedure; cardiopulmonary resuscitation; and REBOA-specific variables (time to procedure, procedure-related time intervals, access site, technique, sheath size, catheter length, balloon volume, deployment zone). Predictive models for survival at three different time points along the trauma triage and REBOA process timeline ("Admission," "REBOA Initiation," and "Postaortic Occlusion") were devised by logistic regression.

RESULTS: Eighty-eight patients had REBOA placement. The Admission model selected age, Glasgow Coma Scale, and admission systolic blood pressure as significant predictors of survival (area under the receiver operating characteristic curve [AUROC], 0.86; 95% CI, 0.77-0.94). The REBOA Initiation and Postaortic Occlusion models selected age, Glasgow Coma Scale, and the systolic blood pressure measured just before balloon inflation as predictors for survival (AUROC, 0.87 [95% CI, 0.78-0.97] and AUROC, 0.90 [95% CI, 0.81-0.99], respectively). No REBOA procedural variables were identified as predictors of patient survival.

CONCLUSION: Only patient-specific criteria of age, neurologic status, and severity of shock predicted survival. The hemodynamic stability of the patient at the time REBOA is initiated is more important than how REBOA is initiated. These findings suggest that earlier preparation for REBOA placement may be a key to improved survival.

LEVEL OF EVIDENCE: Therapeutic, level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Cralley AL, Moore EE, Scalea TM, et al. Predicting success of resuscitative endovascular occlusion of the aorta: Timing supersedes variable techniques in predicting patient survival. J Trauma Acute Care Surg. 2021. PMID: 34086662. doi:10.1097/TA.0000000000003307

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。